BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo

Ross, R, Corinaldesi, C, Migneco, G et al. (5 more authors) (2019) BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Metadata

Authors/Creators:
Keywords: animal models and monoclonal antibodies, interferon, Scleroderma, Skin fibrosis
Dates:
  • Published: October 2019
Institution: The University of Leeds
Funding Information:
FunderGrant number
Capella Bioscience LtdNOEXT REF GIVEN
Depositing User: Symplectic Publications
Date Deposited: 20 Aug 2020 12:20
Last Modified: 20 Aug 2020 12:20
Status: Published

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)